Jump to content

Rudi Mariën

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 13:37, 2 January 2020 (Sources: Task 15: language icon template(s) replaced (1×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Rudi Mariën is a Belgian scientist and businessman. He is Chairman of the Belgian biotech company Innogenetics.

Education

Rudi Mariën obtained a degree in pharmaceutical sciences from the University of Ghent, specializing in clinical biology.

Career

On 18 July 1985, he co-founded the Belgian biotech company Innogenetics, together with Erik Tambuyzer and Hugo Van Heuverswyn and has been its Chairman since then. Besides Innogenetics, he founded several clinical laboratories. He is at present managing director of BARC NV, an international centralized clinical laboratory. He is also CEO of Gengest BVBA (management company), Biovest CVA, LMA BVBA, Laboraco BVBA, and he is director of DSJ Bruxelles NV and Oystershell NV. Rudi Mariën is a member of the American Association for Clinical Chemistry.

Sources